Latest News

Novavax shares double on Sanofi’s $1.4 billion investment for combo vaccine


The French pharmaceutical giant will work with Novavax to commercialize its existing COVI-19 vaccine and help develop a new combined vaccine for both COVID-19 and Influenza

‘No return’ left for U.S. stock market in 2024, says Goldman’s David Kostin

Previous article

The surprising reason why utilities stocks have suddenly transformed into the hottest sector on Wall Street

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *

More in Latest News